FI66183C - Foerfarande foer framstaellning av farmaceutiskt aktiva n2-arylsulfonyl-l-argininamider och deras farmaceutiskt godtagbara salter - Google Patents

Foerfarande foer framstaellning av farmaceutiskt aktiva n2-arylsulfonyl-l-argininamider och deras farmaceutiskt godtagbara salter Download PDF

Info

Publication number
FI66183C
FI66183C FI792637A FI792637A FI66183C FI 66183 C FI66183 C FI 66183C FI 792637 A FI792637 A FI 792637A FI 792637 A FI792637 A FI 792637A FI 66183 C FI66183 C FI 66183C
Authority
FI
Finland
Prior art keywords
alkyl
methyl
formula
arginyl
quinolinesulfonyl
Prior art date
Application number
FI792637A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI66183B (fi
FI792637A (fi
Inventor
Shosuke Okamoto
Ryoji Kikumoto
Yoshikuni Tamao
Kazuo Ohkubo
Shinji Tonomura
Akiko Hijikata
Tohru Tezuka
Original Assignee
Mitsubishi Chem Ind
Shosuke Okamoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/938,711 external-priority patent/US4201863A/en
Priority claimed from US06/041,419 external-priority patent/US4258192A/en
Application filed by Mitsubishi Chem Ind, Shosuke Okamoto filed Critical Mitsubishi Chem Ind
Publication of FI792637A publication Critical patent/FI792637A/fi
Application granted granted Critical
Publication of FI66183B publication Critical patent/FI66183B/fi
Publication of FI66183C publication Critical patent/FI66183C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
FI792637A 1978-08-31 1979-08-23 Foerfarande foer framstaellning av farmaceutiskt aktiva n2-arylsulfonyl-l-argininamider och deras farmaceutiskt godtagbara salter FI66183C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US93871178 1978-08-31
US05/938,711 US4201863A (en) 1974-11-08 1978-08-31 N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4141979 1979-05-22
US06/041,419 US4258192A (en) 1977-12-16 1979-05-22 N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof

Publications (3)

Publication Number Publication Date
FI792637A FI792637A (fi) 1980-03-01
FI66183B FI66183B (fi) 1984-05-31
FI66183C true FI66183C (fi) 1984-09-10

Family

ID=26718116

Family Applications (1)

Application Number Title Priority Date Filing Date
FI792637A FI66183C (fi) 1978-08-31 1979-08-23 Foerfarande foer framstaellning av farmaceutiskt aktiva n2-arylsulfonyl-l-argininamider och deras farmaceutiskt godtagbara salter

Country Status (17)

Country Link
EP (1) EP0008746B1 (de)
AU (1) AU520342B2 (de)
CA (1) CA1135698A (de)
CS (1) CS228119B2 (de)
DD (1) DD146600A5 (de)
DE (1) DE2963539D1 (de)
DK (1) DK152495C (de)
ES (1) ES483767A1 (de)
FI (1) FI66183C (de)
GR (1) GR64905B (de)
HU (1) HU179734B (de)
IE (1) IE48623B1 (de)
NO (1) NO151588C (de)
NZ (1) NZ191434A (de)
PH (1) PH15662A (de)
PL (1) PL121663B1 (de)
PT (1) PT70130A (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5993054A (ja) * 1982-11-18 1984-05-29 Asahi Chem Ind Co Ltd イソキノリンスルホン酸アミド誘導体
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
FR2689130B1 (fr) * 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
US5585498A (en) * 1992-03-30 1996-12-17 Synthelabo Imidazole derivatives useful as synthetic intermediates
GB9209032D0 (en) * 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives
JPH06219948A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
JPH06219949A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
FR2702220B1 (fr) * 1993-03-03 1995-05-12 Synthelabo Dédoublement enzymatique de dérivés de 4-alkyl-2-pipéridine-carboxylate et utilisation des composés obtenus, comme intermédiaires de synthèse.
ATE177635T1 (de) * 1993-04-22 1999-04-15 Senju Pharma Co Wässrige arzneizubereitungen enthaltend argatroban und cyclodextrin oder coffein
FR2710066B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2710067B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Procédé de préparation de 2-amino-5-(1H-imidazol-4-yl)-1-oxopentylpipéridine.
FR2710061B1 (fr) * 1993-09-14 1995-12-29 Synthelabo Acides et chlorures d'acides 1,2,3, 4-tétrahydroquinoléine-8-sulfoniques, et leur utilisation comme intermédiaires de synthèse.
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.
FR2718439B3 (fr) * 1994-04-12 1996-02-09 Synthelabo Dérivés de l'acide pipécolique, leur préparation et leur utilisation comme intermédiaires de synthèse.
DE4424828A1 (de) * 1994-07-14 1996-01-18 Thomae Gmbh Dr K Neue substituierte Arylsulfonamide, ihre Herstellung und ihre Verwendung als Arzneimittel
GB9505538D0 (en) * 1995-03-18 1995-05-03 Ciba Geigy Ag New compounds
GB9508622D0 (en) * 1995-04-28 1995-06-14 Pfizer Ltd Therapeutic agants
FR2735469B1 (fr) * 1995-06-13 1997-07-11 Synthelabo N2-(arylsulfonyl)-l-arginylpiperidin-2-carboxylates, leur preparation et leur application en therapeutique
FR2747676B1 (fr) * 1996-04-22 1998-06-05 Synthelabo Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5925760A (en) * 1996-08-07 1999-07-20 Mitsubishi Chemical Corporation Method for preparing N2 -arylsulfonyl-L-argininamides
FR2804682B1 (fr) * 2000-02-09 2002-05-03 Rhodia Chimie Sa Procede de preparation diastereoselective de piperidines fonctionnalisees en positions 2 et 4 utilisables comme intermediaires de synthese
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
CN100427480C (zh) * 2006-11-10 2008-10-22 天津市炜杰科技有限公司 阿加曲班水合物的制备方法
US7915290B2 (en) 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
CN101914133B (zh) * 2008-03-07 2013-01-30 天津市炜杰科技有限公司 一种21(s)阿加曲班的定向合成方法
ITPD20080106A1 (it) 2008-04-07 2009-10-08 Lundbeck Pharmaceuticals Italy Spa Metodo di preparazione di argatroban monoidrato
EP2305646A1 (de) 2009-10-02 2011-04-06 Enantia, S.L. Verfahren zur Herstellung von trans-(2R)-4-substituierten Pipecolinsäuren und Estern davon und darin verwendete Zwischenverbindungen
ITMI20110545A1 (it) 2011-04-04 2012-10-05 Lundbeck Pharmaceuticals Italy S P A Metodo per la preparazione di intermedi di processo per la sintesi di argatroban monoidrato
CN103570803B (zh) * 2012-08-30 2015-06-03 上海科胜药物研发有限公司 一种阿加曲班中间体的制备方法
CN104672132B (zh) * 2013-11-28 2017-06-16 四川科瑞德制药股份有限公司 阿加曲班中间体的合成方法
CN104098647B (zh) * 2014-06-24 2017-12-08 安徽省逸欣铭医药科技有限公司 阿加曲班类似物及其制备方法和医药用途
CN106928199B (zh) * 2017-05-08 2020-06-09 安徽医学高等专科学校 一种嘧啶化合物的晶型c的制备方法和用途
CN109912570A (zh) * 2019-04-04 2019-06-21 天津药物研究院药业有限责任公司 一种阿加曲班中间体酰胺化物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1131621A (en) * 1977-01-19 1982-09-14 Shosuke Okamoto N.sup.2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
GR64905B (en) 1980-06-07
DK152495C (da) 1988-07-25
PH15662A (en) 1983-03-11
CA1135698A (en) 1982-11-16
DK152495B (da) 1988-03-07
NZ191434A (en) 1984-07-06
IE48623B1 (en) 1985-03-20
NO151588B (no) 1985-01-21
EP0008746A1 (de) 1980-03-19
FI66183B (fi) 1984-05-31
AU5048679A (en) 1980-03-06
DK364579A (da) 1980-03-01
IE791565L (en) 1980-02-29
PL121663B1 (en) 1982-05-31
CS228119B2 (en) 1984-05-14
AU520342B2 (en) 1982-01-28
PT70130A (en) 1979-09-01
EP0008746B1 (de) 1982-08-11
FI792637A (fi) 1980-03-01
NO151588C (no) 1985-05-08
ES483767A1 (es) 1980-04-16
DD146600A5 (de) 1981-02-18
NO792823L (no) 1980-03-03
PL218008A1 (de) 1980-05-05
HU179734B (en) 1982-12-28
DE2963539D1 (en) 1982-10-07

Similar Documents

Publication Publication Date Title
FI66183C (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva n2-arylsulfonyl-l-argininamider och deras farmaceutiskt godtagbara salter
DE69127630T2 (de) Verbesserte matrix metallprotease inhibitoren
US5183900A (en) Matrix metalloprotease inhibitors
JP2501252B2 (ja) 酢酸誘導体、その製造法、それを含む製薬調製剤、及びその製薬調製剤製造への利用
US5189178A (en) Matrix metalloprotease inhibitors
US5114953A (en) Treatment for tissue ulceration
US4791102A (en) Derivatives of the N α-arylsulphonylaminoacyl-p-amidinophenylalaninamides, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
JP2000501423A (ja) アリールスルホニルアミノヒドロキサム酸誘導体
KR20140014081A (ko) 아밀로이드 피브릴 형성과 관련된 증상 치료용 디펩티드 유사체
US5270326A (en) Treatment for tissue ulceration
JPS6112911B2 (de)
JP5430559B2 (ja) 新規ぺプチドデホルミラーゼ阻害化合物とその製造方法
JPS6320820B2 (de)
SU1042615A3 (ru) Способ получени N @ -арил-сульфонил- @ -аргининамидов
JPH0653715B2 (ja) ２−アミノアセトアミド誘導体
SU938739A3 (ru) Способ получени N -арилсульфонил-L-аргининамидов или их солей
JPH01501227A (ja) アミノ―２―エタンチオール誘導体、その製造および治療用途
EP0326240B1 (de) 2-Aminoacetamid Derivate
KR820002084B1 (ko) N²-아릴설포닐-l-알기닌아마이드 유도체의 제조방법
JPS58152851A (ja) 腎蔵活性テトラペプチド
JPS6214548B2 (de)
JP2005535715A (ja) グリシン作動性を有するｒ（＋）−２−アミノ−３−ヒドロキシプロピオン酸誘導体
JPS63196558A (ja) ２−アザシクロカルボサキサミド誘導体
HU180265B (hu) Eljárás NJ -aril-szulfonií-L-argínin-amídok és gyógyászatilag elfogadható sóik előállítására

Legal Events

Date Code Title Description
MA Patent expired

Owner name: MITSUBISHI KASEI CORPORATION